TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 11 | -4 | -3 | -0 | -13 | -17 | -4 |
| P | %wins | 100 | 33 | 67 | 33 | 33 | 33 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/08 11:43 | 11/12/08 | DDD | Scolr Pharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mitchel Alan M | WA | O | SVP - GC | P | 3 | 0.8900 | 1 | 3 | 10 | 33 | D | -48 | -56 | -13 | -37 | -39 | -13 | -32 | -15 | 30 | -12 | 3 | -20 | -18 | 27 |
12/10/07 13:41 | 12/7/07 | DDD | Scolr Pharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mitchel Alan M | WA | O | SVP - G | P.m | 10 | 1.28 | 5 | 8 | 300 | 10 | D | -4 | 15 | -14 | -14 | -16 | -8 | -3 | 3 | 2 | -11 | -19 | -21 | -40 | -61 |
3/21/07 13:00 | 3/20/07 | DDD | Scolr Pharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mitchel Alan M | WA | O | GC | P | 6 | 2.40 | 4 | 3 | New | 3 | D | -2 | -21 | 3 | 20 | -7 | -2 | -5 | -1 | 1 | 12 | 8 | 40 | 19 | -18 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |